Diagnosing bladder cancer.

Emerging Technologies

Why Cystoscopy is Still Vital for Bladder Cancer Diagnosis

“Unfortunately, imaging is not very useful in looking for tumors in hollow organs, and that is why people have to do colonoscopy to evaluate the lining of the colon and why we have to do cystoscopy to evaluate the lining of the bladder,” Dr. Yair Lotan said.

Many advances have been made in detecting and treating bladder cancer in recent years, but cystoscopy remains the gold standard in diagnosing the disease.

This is according to Dr. Yair Lotan, professor of urology and chief of urologic oncology at UT Southwestern Medical Center. He recently discussed alternatives to cystoscopy for bladder cancer diagnosis and why each must be used along with, instead of in place of, cystoscopy on the Bladder Cancer Matters podcast.

Lotan said cystoscopy should be the main tool to examine a patient with blood in the urine, the most common sign of bladder cancer. The evaluation usually includes imaging — either a CT scan or an ultrasound.

Large tumors or growths can be seen through imaging, but many bladder cancer tumors are smaller. And if the bladder is collapsed, imaging cannot detect solid areas within the bladder, Lotan explained.

“Unfortunately, imaging is not very useful in looking for tumors in hollow organs, and that is why people have to do colonoscopy to evaluate the lining of the colon and why we have to do cystoscopy to evaluate the lining of the bladder,” he said.

Alternatives to Cystoscopy

Tools to detect bladder cancer through blood samples have not been validated and are not yet commercially recommended.

Urine markers, however, recently received FDA approval. These take a close look at biomarkers such as DNA, RNA, or proteins.

“The problem with some of these markers is that they can also miss some high-grade cancers and they also have the potential for false positive results,” Lotan said. “They are being used in various different clinical scenarios, but not yet to replace cystoscopy.”

Then there's cytology, the process of examining urine for any suspicious cells. It has a low sensitivity to low-grade cancers, Lotan said, and can miss between 30 percent and 50 percent of high-grade cancers.

Because cystoscopy relies on the urologist to spot cancerous tumors, which can be difficult to detect when small or flat, cytology serves “as an adjunct measure to try to catch any cancers that were missed,” he added.

More Urology Articles
Why Duke University Urologists Prefer Single-Use
Emerging Technologies
A benchtop and initial clinical assessment out of Duke University found a single-use cystoscope to rate higher than its reusable counterpart in many key areas.
Why Cystoscopy is Still Vital for Bladder Cancer Diagnosis
Emerging Technologies
Novel ways of detecting bladder cancer may serve as an adjunct to cystoscopy, but none are yet advanced enough to be used on their own, says one expert.
More From Single-Use Endoscopy

Endoscopy Tech

A new system enables urologists to perform various endoscopic procedures with nothing more than a scope and their smartphone.

CRC screening to begin at age 45.

Gastrointestinal Endoscopy Applications

GI endoscopists celebrate updated guidance for colorectal cancer screening to begin at 45.

Challenges in device reprocessing are related to the lack of connection that hospital administrators and the public at large make between the resources given to our teams and the ultimate quality of surgical instruments available for every procedure.

Preventing Infection

Bigger hospitals typically offer more complex services, putting added strain on reprocessing departments — and the quality of reprocessing depends on the resources made available to the teams that do that work.